Noel Whitcher - American Rare Joint CFO
ARRNF Stock | USD 0.19 0.01 5.56% |
Insider
Noel Whitcher is Joint CFO of American Rare Earths
Phone | 61 2 8054 9779 |
Web | https://americanrareearths.com.au |
American Rare Management Efficiency
The company has return on total asset (ROA) of (0.1801) % which means that it has lost $0.1801 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1597) %, meaning that it generated substantial loss on money invested by shareholders. American Rare's management efficiency ratios could be used to measure how well American Rare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Christine McCarthy | Procter Gamble | 65 | |
Mikael Grubb | JPMorgan Chase Co | N/A | |
Debra Lee | Procter Gamble | 66 | |
Deepak Khanna | Merck Company | N/A | |
Jannie Oosthuizen | Merck Company | 53 | |
Edward Gillespie | ATT Inc | 59 | |
Victor Aguilar | Procter Gamble | 53 | |
Antonino MBA | Liontown Resources Limited | N/A | |
Mindy Sherwood | Procter Gamble | N/A | |
Kirti Singh | Procter Gamble | N/A | |
Grant Donald | Liontown Resources Limited | N/A | |
Henry Karamanoukian | Procter Gamble | N/A | |
Ken Patel | Procter Gamble | N/A | |
Risa LavizzoMourey | Merck Company | 66 | |
Debra Lee | ATT Inc | 66 | |
Michael Fleming | Merck Company | 61 | |
Jennifer Davis | Procter Gamble | 52 | |
Gary Marvel | Caterpillar | 58 | |
Loic Tassel | Procter Gamble | N/A | |
Laura Becker | Procter Gamble | N/A | |
Anthony Fassino | Caterpillar | 49 |
Management Performance
Return On Equity | -0.16 | |||
Return On Asset | -0.18 |
American Rare Earths Leadership Team
Elected by the shareholders, the American Rare's board of directors comprises two types of representatives: American Rare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of American. The board's role is to monitor American Rare's management team and ensure that shareholders' interests are well served. American Rare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, American Rare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dwight Kinnes, Chief Officer | ||
Alan Deans, Communications Consultant | ||
Noel Whitcher, Joint CFO | ||
BA AIM, MD CEO | ||
Jim Guilinger, Chief Advisor | ||
ACIS ACA, Joint Sec | ||
B MSc, Geological Consultant |
American Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is American Rare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.16 | |||
Return On Asset | -0.18 | |||
Operating Margin | (94.51) % | |||
Current Valuation | 54.81 M | |||
Shares Outstanding | 446.38 M | |||
Shares Owned By Insiders | 27.52 % | |||
Shares Owned By Institutions | 16.31 % | |||
Price To Book | 6.79 X | |||
Price To Sales | 1,525 X | |||
Revenue | 40.97 K |
Currently Active Assets on Macroaxis
Other Information on Investing in American OTC Stock
American Rare financial ratios help investors to determine whether American OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in American with respect to the benefits of owning American Rare security.